Table 2.
Comparison of clinical outcomes between the ONSD < 5 mm and the ONSD ≥ 5 mm.
| Total (n = 186) | ONSD<5 mm (n = 98) | ONSD≧5 mm (n = 88) | p | |
|---|---|---|---|---|
| Primary outcomes | ||||
| In-hospital mortality (n, %) | 42 (22.6) | 12 (12.2) | 30 (34.1) | 0.017 |
| Early neurological deterioration (n, %) | 58 (31.2) | 18 (18.4) | 40 (45.5) | 0.023 |
| Hematoma expansion (n, %) | 64 (34.4) | 20 (20.4) | 44 (50.0) | <0.001 |
| Secondary outcomes | ||||
| mRS at discharge [M (P25, P75)] | 4 (2, 6) | 3 (1, 4) | 5 (4, 6) | 0.013 |
| Death or dependency at discharge (n, %) | 124 | 48 (49.0) | 76 (86.4) | <0.001 |
| 30 d mortality (n, %) | 59 (31.7) | 25 (25.5) | 34 (38.6) | 0.012 |
mRS, modified Rankin scale.